CV Sciences, Inc. financial data

Symbol
CVSI on OTC
Industry
Pharmaceutical Preparations
Location
9530 Padgett Street, Suite 107, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
CannaVEST Corp. (to 1/4/2016), Foreclosure Solutions, Inc. (to 11/30/2012)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 119 % -2.05%
Quick Ratio 89.2 % +13.9%
Debt-to-equity 251 % -9.02%
Return On Equity -102 % -279%
Return On Assets -29 % -291%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 184M shares +19.2%
Common Stock, Shares, Outstanding 184M shares +19.2%
Entity Public Float 6M USD 0%
Common Stock, Value, Issued 18K USD +20%
Weighted Average Number of Shares Outstanding, Basic 182M shares +17.9%
Weighted Average Number of Shares Outstanding, Diluted 182M shares +17.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 15.6M USD -2.8%
Cost of Revenue 8.39M USD -8.49%
Research and Development Expense 133K USD -11.9%
Operating Income (Loss) -2.43M USD -215%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.54M USD -2.01%
Income Tax Expense (Benefit) -3K USD
Net Income (Loss) Attributable to Parent -2.54M USD -253%
Earnings Per Share, Basic -0.01 USD/shares -150%
Earnings Per Share, Diluted -0.01 USD/shares -150%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 611K USD -55.6%
Accounts Receivable, after Allowance for Credit Loss, Current 422K USD -36.6%
Inventory, Net 5.02M USD -12.4%
Assets, Current 6.75M USD -20.1%
Property, Plant and Equipment, Net 490K USD +22.8%
Operating Lease, Right-of-Use Asset 81K USD -58.5%
Intangible Assets, Net (Excluding Goodwill) 103K USD -59%
Goodwill 815K USD
Other Assets, Noncurrent 154K USD -55.7%
Assets 8.39M USD -13%
Accounts Payable, Current 1.89M USD -28.1%
Accrued Liabilities, Current 3.42M USD +3.35%
Liabilities, Current 6.14M USD +1.35%
Deferred Income Tax Liabilities, Net 19K USD +72.7%
Operating Lease, Liability, Noncurrent 0 USD -100%
Other Liabilities, Noncurrent 38K USD
Liabilities 6.2M USD +0.58%
Accumulated Other Comprehensive Income (Loss), Net of Tax 19K USD
Retained Earnings (Accumulated Deficit) -86.3M USD -3.03%
Stockholders' Equity Attributable to Parent 2.19M USD -37%
Liabilities and Equity 8.39M USD -13%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -518K USD -153%
Net Cash Provided by (Used in) Financing Activities -136K USD +84.4%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 790M shares 0%
Common Stock, Shares, Issued 184M shares +19.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -655K USD -736%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 979K USD -40.4%
Deferred Tax Assets, Valuation Allowance 17M USD -3.73%
Deferred Tax Assets, Gross 17.1M USD -4.28%
Operating Lease, Liability 92K USD -58%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -2.52M USD +2.69%
Lessee, Operating Lease, Liability, to be Paid 94K USD -59.7%
Property, Plant and Equipment, Gross 1.43M USD +2.73%
Operating Lease, Liability, Current 92K USD -27.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 147K USD +149%
Lessee, Operating Lease, Liability, to be Paid, Year One 59K USD -57.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2K USD -85.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 37K USD
Deferred Tax Assets, Operating Loss Carryforwards 10.8M USD +16.4%
Preferred Stock, Shares Issued 1K shares 0%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 170K USD -1.16%
Additional Paid in Capital 88.4M USD +1.41%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 4K USD
Depreciation, Depletion and Amortization 63K USD +6.78%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%